310 related articles for article (PubMed ID: 2994869)
1. Ca2+ channel antagonist actions in bladder smooth muscle: comparative pharmacologic and [3H]nitrendipine binding studies.
Yousif FB; Bolger GT; Ruzycky A; Triggle DJ
Can J Physiol Pharmacol; 1985 May; 63(5):453-62. PubMed ID: 2994869
[TBL] [Abstract][Full Text] [Related]
2. Characterization of binding of the Ca++ channel antagonist, [3H]nitrendipine, to guinea-pig ileal smooth muscle.
Bolger GT; Gengo P; Klockowski R; Luchowski E; Siegel H; Janis RA; Triggle AM; Triggle DJ
J Pharmacol Exp Ther; 1983 May; 225(2):291-309. PubMed ID: 6842393
[TBL] [Abstract][Full Text] [Related]
3. Inhibitory actions of a series of Ca2+ channel antagonists against agonist and K+ depolarization induced responses in smooth muscle: an assessment of selectivity of action.
Yousif FB; Triggle DJ
Can J Physiol Pharmacol; 1986 Mar; 64(3):273-83. PubMed ID: 2423216
[TBL] [Abstract][Full Text] [Related]
4. Discrimination by nimodipine, but not by nifedipine, between phasic and tonic contractions of guinea-pig taenia coli induced by K+ depolarization.
Usune S; Katsuragi T; Furukawa T
Can J Physiol Pharmacol; 1995 Nov; 73(11):1600-4. PubMed ID: 8789414
[TBL] [Abstract][Full Text] [Related]
5. Calcium channel antagonist binding and pharmacology in rat uterine smooth muscle.
Grover AK; Oakes PJ
Life Sci; 1985 Dec; 37(23):2187-92. PubMed ID: 2933568
[TBL] [Abstract][Full Text] [Related]
6. Identification of calcium antagonist receptor binding sites using (3H)nitrendipine in bovine tracheal smooth muscle membranes.
Cheng JB; Bewtra A; Townley RG
Experientia; 1984 Mar; 40(3):267-9. PubMed ID: 6321228
[TBL] [Abstract][Full Text] [Related]
7. Functional interactions of calcium-antagonists in K+-depolarized smooth muscle.
Spedding M
Br J Pharmacol; 1983 Nov; 80(3):485-8. PubMed ID: 6640202
[TBL] [Abstract][Full Text] [Related]
8. Stimulation of Na+,K+-ATPase of isolated smooth muscle membranes by the Ca2+ channel inhibitors, nimodipine and nitrendipine.
Pan M; Janis RA
Biochem Pharmacol; 1984 Mar; 33(5):787-91. PubMed ID: 6324799
[TBL] [Abstract][Full Text] [Related]
9. Specific and non-specific desensitization of guinea-pig ileal smooth muscle.
Siegel H; Jim K; Bolger GT; Gengo P; Triggle DJ
J Auton Pharmacol; 1984 Jun; 4(2):109-25. PubMed ID: 6204987
[TBL] [Abstract][Full Text] [Related]
10. Binding of [3H]nimodipine to cardiac and smooth muscle membranes.
Janis RA; Maurer SC; Sarmiento JG; Bolger GT; Triggle DJ
Eur J Pharmacol; 1982 Aug; 82(3-4):191-4. PubMed ID: 7128686
[TBL] [Abstract][Full Text] [Related]
11. Specific high affinity binding of the calcium channel antagonist, [3H]nitrendipine, to rat liver microsomes.
Gopalakrishnan V; Triggle CR
Can J Physiol Pharmacol; 1984 Sep; 62(9):1249-52. PubMed ID: 6498637
[TBL] [Abstract][Full Text] [Related]
12. In vitro and in vivo characterization of 2,6-dimethyl-3,5-dicarbomethoxy-4-(2-isothiocyano)phenyl-1,4- dihydropy ridine as a Ca2+ channel antagonist.
Gengo P; Su CM; Yousif FB; Triggle DJ
Can J Physiol Pharmacol; 1987 Dec; 65(12):2472-82. PubMed ID: 3449204
[TBL] [Abstract][Full Text] [Related]
13. SR 33557, a novel calcium-antagonist: interaction with [3H]-(+/-)-nitrendipine and [3H]-(-)-desmethoxy-verapamil binding sites in cerebral membranes.
Nokin P; Clinet M; Polster P; Beaufort P; Meysmans L; Gougat J; Chatelain P
Naunyn Schmiedebergs Arch Pharmacol; 1989; 339(1-2):31-6. PubMed ID: 2542806
[TBL] [Abstract][Full Text] [Related]
14. Tissue response selectivity of calcium antagonists is not due to heterogeneity of [3H]-nitrendipine binding sites.
Bristow MR; Ginsburg R; Laser JA; McAuley BJ; Minobe W
Br J Pharmacol; 1984 Jun; 82(2):309-20. PubMed ID: 6329392
[TBL] [Abstract][Full Text] [Related]
15. Differential labelling of putative skeletal muscle calcium channels by [3H]-nifedipine, [3H]-nitrendipine, [3H]-nimodipine and [3H]-PN 200 110.
Ferry DR; Goll A; Glossmann H
Naunyn Schmiedebergs Arch Pharmacol; 1983 Jul; 323(3):276-7. PubMed ID: 6312337
[TBL] [Abstract][Full Text] [Related]
16. Molecular approach to the calcium channel.
Glossmann H; Ferry DR; Goll A; Linn T
Adv Myocardiol; 1985; 5():41-76. PubMed ID: 2578683
[TBL] [Abstract][Full Text] [Related]
17. Interaction of phenoxybenzamine with muscarinic receptors and calcium channels.
Gengo PJ; Yousif F; Janis RA; Triggle DJ
Biochem Pharmacol; 1984 Nov; 33(21):3445-9. PubMed ID: 6093812
[TBL] [Abstract][Full Text] [Related]
18. Characterization of [3H]-nitrendipine binding to uterine smooth muscle plasma membrane and its relevance to inhibition of calcium entry.
Batra S
Br J Pharmacol; 1985 Aug; 85(4):767-74. PubMed ID: 2412621
[TBL] [Abstract][Full Text] [Related]
19. Potential-dependent interactions of nitrendipine and related 1,4-dihydropyridines in functional smooth muscle preparations.
Triggle DJ; Hawthorn M; Zheng W
J Cardiovasc Pharmacol; 1988; 12 Suppl 4():S91-3. PubMed ID: 2468883
[TBL] [Abstract][Full Text] [Related]
20. High-affinity antibodies to the 1,4-dihydropyridine Ca2+-channel blockers.
Campbell KP; Sharp A; Strom M; Kahl SD
Proc Natl Acad Sci U S A; 1986 May; 83(9):2792-6. PubMed ID: 3010317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
